Compare ELAB & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELAB | SILO |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Apparel |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.5M |
| IPO Year | 2023 | N/A |
| Metric | ELAB | SILO |
|---|---|---|
| Price | $5.81 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 501.4K | 186.2K |
| Earning Date | 03-27-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $285,948.00 | $72,102.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.62 | $0.33 |
| 52 Week High | $398.86 | $3.37 |
| Indicator | ELAB | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 72.16 | 45.03 |
| Support Level | $1.25 | $0.33 |
| Resistance Level | $9.59 | $0.43 |
| Average True Range (ATR) | 0.76 | 0.03 |
| MACD | 0.46 | 0.00 |
| Stochastic Oscillator | 55.22 | 48.67 |
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.